Pharma braces for critical French drug pricing reforms pending CEPS’s report
Growing budgetary pressure is a central theme in France as the country prepares for the publication of the government's 2026…
Pricing and Market Access
Uruguay progresses towards developing its first regulatory agency
Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade
The European Market Access Lag: 2021–2024
Trump revives plan for IRP use in US via MFN executive order
5EU Q1 2024 versus 2025: Pricing shifts, HTA outcomes, and innovative drug trends
First two medicinal products to undergo EU joint clinical assessments announced
Ukraine ramps up cost-containment measures to “stabilise” retail drug market
